Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis |
| |
| Authors: | Jai Grewal Santosh Kesari |
| |
| Affiliation: | 1.Long Island Center for Brain and Spine Tumors 600 Northern Blvd, suite 113, Great Neck, NY 11021, 516-478-0010, USA;2.Center for Neuro-Oncology, Dana-Farber/Brigham and Women''s Cancer Center and Division of Cancer Neurology, Department of Neurology, Brigham and Women''s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA |
| |
| Abstract: | Determining the status of breast cancer surface receptors (estrogen receptor, progesterone receptor, HER2/neu) has become
routine in the care of patients with this disease and has proven to be helpful in guiding treatment. For this reason, breast
cancer has become a model for molecularly guided therapy in solid tumors. Emerging data support that these receptors are associated
with risk for developing brain metastases. Additionally, once brain metastases have occurred these receptors may also correlate
with prognosis. |
| |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
